Live donor kidney transplantation in a patient with antithrombin deficiency

Transplantation

Volumn 84, Issue 7, 2007, Pages 937-938

  Patel, Jitesh A ^a   Nghiem, Dai D ^a   Sureshkumar, Kalathil K ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; WARFARIN; ANTITHROMBIN;

ADULT; ANTITHROMBIN DEFICIENCY; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; KIDNEY VEIN THROMBOSIS; LETTER; LIVING DONOR; MOTHER; NEPHRECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; ANTITHROMBIN III DEFICIENCY; CASE REPORT; CHRONIC KIDNEY FAILURE; KIDNEY DISEASE; METABOLISM; METHODOLOGY; NEPHROTIC SYNDROME; TIME; TREATMENT OUTCOME;

ADULT; ANTITHROMBIN III DEFICIENCY; ANTITHROMBINS; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; NEPHROTIC SYNDROME; TIME FACTORS; TREATMENT OUTCOME;

EID: 38449108519     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000281919.85947.ef     Document Type: Letter

References (4)

1. Fischereder M, Gohring P, Schneeberger H, et al. Early loss of renal transplants in patients with thrombophilia. Transplantation 1998; 65: 936.
2. Heidenreich S, Junker R, Wolters H, et al. Outcome of kidney transplantation in patients with inherited thrombophilia: Data of a prospective study. J Am Soc Nephrol 2003; 14: 234.
3. Schwartz RS, Bauer KA, Rosenberg RD, et al. Clinical experience with antithrombin III concentrate in the treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group. Am J Med 1989; 87: 53S.
4. Konkle BA, Bauer KA, Weinstein AG, Holmes HE, Bonfiglio J. Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures. Transfusion 2003; 43: 39.